Long non-coding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetical

来源 :2015苏浙皖赣肿瘤内科治疗进展高峰论坛暨江苏省第七次肿瘤化疗与生物治疗学术会议 | 被引量 : 0次 | 上传用户:ainyli
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Long non-coding RNAs (lncRNAs) are a novel class of transcripts with no protein coding capacity, but with diverse functions in cancer cell proliferation, apoptosis and metastasis.
其他文献
Background: Increasing evidence indicates that dysregulation of microRNAs (miRNAs) plays critical roles in malignant transformation and tumor progression.Previously, we have shown that microRNA-451 (m
会议
Serum thymidine kinase 1 (STK1) is a reliable proliferation marker in most of solid tumors, including gastric cancer.The aim of this study was to evaluate whether the STK1 levels were related to tumor
会议
Background: To date, the association between 8q24.21-rs6983267 (T>G) polymorphism and risk of digestive tract cancer remains inconclusive.To derive a more precise estimation of the association, we con
会议
Objective: Patients with inflammatory bowel disease (IBD) are associated with an increased risk of extra-intestinal cancer, whereas its impact on cholangiocarcinoma (CC) remains unknown.The aim of thi
会议
AIM: To study the mechanism and effect of down-regulation of Histone Deacetylase 1 (HDAC1) by microRNA-520h in the chemotherapeutic effect of doxorubicin.METHOD: Down-regulation of HDAC1 by doxorubici
Long noncoding RNAs (lncRNAs) have been identified as oncogenes or tumor suppressors that are involved in tumorigenesis and chemotherapy drug resistance.Maternally expressed gene 3 (MEG3) is an imprin
会议
旨在研究B细胞激活因子(BAFF)和增殖诱导配体(APRIL)在慢性淋巴细胞白血病(CLL)的表达以及与CLL预后指标的相关性,探讨其在CLL预后中的意义.认为CLL患者存在BAFF和APRIL基因的高表达,BAFF基因表达水平与Binet分期明显相关,具有一定的预后意义。
本次临床实践研究主要选取了2012年3月-2015年3月期间,本院所收治的52例肿瘤患者作为临床实践研究的对象,对52例患者进行植入式静脉输液港治疗,观察52例患者治疗中的并发症发生情况,分析患者并发症状发生的原因.结果表明52例患者中,管道堵塞2例,输液外渗4例,气胸1例,皮下出血1例,并发症状的发生几率为15.38%.并发症发生的原因主要为长时间强迫穿刺侧半卧位,穿刺过程中忽视对患者穿刺点的观
Background: Chemoresistance is the most significant obstacle of the clinical chemotherapeutic efficacy in advanced lung adenocarcinoma (LAD) so far.
会议
Background miR-203 has been reported to have aberrant expression in many tumor types including esophageal cancer and the methylation of promoter CpG islands miR-203 has not been comprehensively invest